26th Jan 2021 11:54
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 25 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,423,218 | 1.88% | 612,248 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
273,127 | 0.21% | 445,393 | 0.35% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
2,702,345 | 2.10% | 1,063,641 | 0.83% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 209.2450 USD |
| Purchase | 20 | 208.9550 USD |
| Purchase | 25 | 209.4064 USD |
| Purchase | 67 | 209.5500 USD |
| Purchase | 79 | 209.4203 USD |
| Purchase | 100 | 209.5960 USD |
| Purchase | 147 | 209.0653 USD |
| Purchase | 267 | 209.3999 USD |
| Purchase | 285 | 209.5730 USD |
| Purchase | 290 | 209.5779 USD |
| Purchase | 363 | 209.2427 USD |
| Purchase | 390 | 209.3350 USD |
| Purchase | 401 | 209.3751 USD |
| Purchase | 420 | 209.2664 USD |
| Purchase | 508 | 209.7175 USD |
| Purchase | 573 | 209.5053 USD |
| Purchase | 585 | 209.4648 USD |
| Purchase | 714 | 209.4286 USD |
| Purchase | 883 | 209.2156 USD |
| Purchase | 1,238 | 208.4358 USD |
| Purchase | 1,260 | 208.4543 USD |
| Purchase | 1,671 | 208.8953 USD |
| Purchase | 2,231 | 209.3015 USD |
| Purchase | 4,312 | 209.2118 USD |
| Purchase | 4,407 | 209.3200 USD |
| Purchase | 12,673 | 209.3219 USD |
| Purchase | 19,821 | 209.1204 USD |
| Purchase | 36,159 | 209.2809 USD |
| Sale | 14 | 209.3092 USD |
| Sale | 47 | 208.9700 USD |
| Sale | 71 | 208.6501 USD |
| Sale | 74 | 209.1445 USD |
| Sale | 100 | 208.9400 USD |
| Sale | 100 | 209.9400 USD |
| Sale | 115 | 208.9900 USD |
| Sale | 142 | 209.5327 USD |
| Sale | 200 | 209.5650 USD |
| Sale | 336 | 208.7432 USD |
| Sale | 387 | 209.4726 USD |
| Sale | 398 | 209.5216 USD |
| Sale | 403 | 209.1686 USD |
| Sale | 412 | 209.2475 USD |
| Sale | 465 | 207.0995 USD |
| Sale | 500 | 209.1800 USD |
| Sale | 500 | 209.3190 USD |
| Sale | 730 | 209.3215 USD |
| Sale | 873 | 209.1569 USD |
| Sale | 945 | 209.1646 USD |
| Sale | 1,374 | 209.3865 USD |
| Sale | 1,456 | 208.9302 USD |
| Sale | 1,495 | 209.3578 USD |
| Sale | 1,688 | 209.2973 USD |
| Sale | 1,825 | 209.4615 USD |
| Sale | 2,462 | 209.4415 USD |
| Sale | 3,612 | 209.1775 USD |
| Sale | 4,782 | 209.3516 USD |
| Sale | 5,186 | 208.9761 USD |
| Sale | 6,672 | 209.3200 USD |
| Sale | 8,352 | 209.2499 USD |
| Sale | 9,019 | 209.2282 USD |
| Sale | 10,693 | 209.3291 USD |
| Sale | 11,182 | 209.3173 USD |
| Sale | 12,518 | 209.0584 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 26 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
|
| or derivative |
|
|
|
|
| relates |
|
|
|
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel
View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005591/en/
Copyright Business Wire 2021
Related Shares:
Barclays